1
Results: The median survival time of patients receiving PC was 19 months.
2
Patients receiving chemotherapy alone showed a median survival rate of 115 days.
3
The median survival time of patients managed with PI was 23 months.
4
A 14-month median survival time was estimated for all patients, so far.
5
The coordinated sequence of therapies allows median survival times of 20 months.
6
The overall median survival of transplanted patients has not yet been reached.
7
The median survival duration for all 21 patients has not been reached.
8
Clinical outcome was poor with a median survival time of 5 months.
9
No objective response was seen, and the median survival time was 10 months.
10
Results: The median survival time of the patients was 33 months.
11
About half the patients respond to treatment, with median survival of 4 months.
12
Statistically significantly longer estimated median survival was noted for patients who received FCR.
13
The median survival time of patients who are still alive was 13 months.
14
The median survival time was not significantly different in the two treatment series.
15
Our results imply that curative resection leads to an increase in median survival.
16
These patients have done well, and the median survival has reached 8 years.
